Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Breast cancer research and treatment"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Liu%2C+Mei%22&type=Person&filter%5B%5D=journalStr%3A%22Breast+cancer+research+and+treatment%22
/vufind/Search/Results?lookfor=%22Liu%2C+Mei%22&type=Person&filter%5B%5D=journalStr%3A%22Breast+cancer+research+and+treatment%22
Search /vufind/Search2/Results?lookfor=%22Liu%2C+Mei%22&type=Person&filter%5B%5D=journalStr%3A%22Breast+cancer+research+and+treatment%22
PubPharm (26)
1
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2) : an open-label, multicenter, phase II trial
enthalten in:
Breast cancer research and treatment
| 2022
von
Hickish, T.
|
Mehta, A.
|
Liu, M.
| +11
Wird geladen...
2
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial
enthalten in:
Breast cancer research and treatment
| 2022
von
Hickish, T.
|
Mehta, A.
|
Liu, M.
| +11
Wird geladen...
3
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial
enthalten in:
Breast cancer research and treatment
| 2022
von
Hickish, T.
|
Mehta, A.
|
Liu, M.
| +11
Wird geladen...
4
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial
enthalten in:
Breast cancer research and treatment
| 2022
von
Hickish, T.
|
Mehta, A.
|
Liu, M.
| +11
Wird geladen...
5
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study
enthalten in:
Breast cancer research and treatment
| 2021
von
Huang, C.
|
Yang, Y.
|
Kwong, A.
| +10
Wird geladen...
6
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study
enthalten in:
Breast cancer research and treatment
| 2021
von
Huang, C.
|
Yang, Y.
|
Kwong, A.
| +10
Wird geladen...
7
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study
enthalten in:
Breast cancer research and treatment
| 2021
von
Huang, C.
|
Yang, Y.
|
Kwong, A.
| +10
Wird geladen...
8
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study
enthalten in:
Breast cancer research and treatment
| 2021
von
Huang, C.
|
Yang, Y.
|
Kwong, A.
| +10
Wird geladen...
9
Effect of a multidiscipline mentor-based program, Be Resilient to Breast Cancer (BRBC), on female breast cancer survivors in mainland China-A randomized, controlled, theoretically-derived intervention trial
enthalten in:
Breast cancer research and treatment
| 2016
von
Ye, Z.
|
Liang, M.
|
Qiu, H.
| +6
Wird geladen...
10
Effect of a multidiscipline mentor-based program, Be Resilient to Breast Cancer (BRBC), on female breast cancer survivors in mainland China—A randomized, controlled, theoretically-derived intervention trial
enthalten in:
Breast cancer research and treatment
| 2016
von
Ye, Z.
|
Liang, M.
|
Qiu, H.
| +6
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Breast cancer research and treatment
Medienart
26
Aufsätze
17
E-Artikel
17
E-Ressourcen
9
Gedruckte Aufsätze
Zeitschriftentitel
Breast cancer research and treatment
Thema
6
Journal Article
4
Afatinib
4
Breast cancer
4
Capecitabine
4
Chinesisch
4
Early breast cancer
4
ErbB
4
HER2
4
HER2-positive
4
Invasive disease-free survival (IDFS)
4
Mainland China
4
Mentor-based
4
Metastatic breast cancer
4
Multicenter Study
4
Multidiscipline
4
Randomized trial
4
Resilience
4
Resistance
4
Survivors
4
Theoretically-derived
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
8
2020-
8
2010-2019
10
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
26
Englisch
Haven't found what you're looking for?
Wird geladen...